Medical Image Analysis Software Market by Function (Reconstruction, Detection, Analysis, Reporting), Tech (AI [ML, Computer Vision), Image (3D, 4D), Modality (CT, PET/SPECT, Mammo), Indication (Onco, Cardio), End User (Hospital) - Global Forecast to 2031

Market Size
$4.35B
MARKET SIZE, 2026
Projected Market Size
$6.42B
MARKET SIZE, 2031
CAGR
8.1%
CAGR (2026-2031)
Forecast Period
2026-2031
FORECAST PERIOD

MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, SHARE & GROWTH SNAPSHOT

medical-image-analysis-software-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global medical image analysis software market is projected to grow from USD 4.35 billion in 2026 to USD 6.42 billion by 2031, at a CAGR of 8.1% during the forecast period. The market was valued at USD 4.04 billion in 2025. The growth of the medical image analysis software market is driven by the increasing need to reduce radiologist workload, improve diagnostic turnaround time, and manage rising imaging volumes across hospitals, diagnostic centers, and research institutions. Healthcare organizations are adopting AI-enabled software for image detection, segmentation, reconstruction, registration, reporting, and clinical decision support across CT, MRI, ultrasound, mammography, and nuclear imaging.

KEY TAKEAWAYS

  • MARKET SNAPSHOT:
    Base Year Market Size (2025): USD 4.04 Billion
    Current Market Size (2026): USD 4.35 Billion
    Forecast Market Size (2031): USD 6.42 Billion
    CAGR (2026–2031): 8.1%
  • SEGMENT LEADERSHIP:
    Regional Leader: North America dominated the market with a share of 38.4% in 2025.
    Software Leader: Integrated software segment held the largest market share of 64.5% in 2025.
    Technology Leader: AI-enabled technology segment is expected to register the highest CAGR of 8.6% during the forecast period.
    Detection & Localization: The detection & localization segment is expected to register the highest CAGR during the forecast period.
    Imaging Leader: 3D imaging segment accounted for the largest market share in 2025.
    Imaging Modality Leader: Computed tomography (CT) segment held the largest market share in 2025.
    Application Leader: Cardiology segment held the largest market share in 2025.
    End User Leader: Hospitals segment held the largest market share in 2025, while diagnostic imaging centers segment is expected to register the highest CAGR during the forecast period.
  • MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
    Siemens Healthineers AG, GE HealthCare, and Koninklijke Philips N.V. were identified as some of the star players in the medical image analysis software market, given their strong market share and product footprint.
    Viz.ai, Inc. and Aidoc Medical have distinguished themselves among startups and SMEs by establishing strong footholds in specialized niches, underscoring their potential as emerging market leaders.

Demand for medical image analysis software is growing as hospitals and diagnostic centers look to reduce radiologist workload and improve diagnostic turnaround time. It supports functions such as detection & localization, segmentation & analysis, reconstruction & visualization, registration & comparison, reporting & communication, and clinical decision support.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

Trend disruption in the medical image analysis software market is mainly driven by the shift from conventional, rule-based image processing to AI-enabled detection, deep learning reconstruction, cloud-native platforms, and integrated hardware-software models. Hospitals, diagnostic imaging centers, and research institutions are using AI-based software to reduce manual review time in detection & localization, segmentation & analysis, reconstruction & visualization, reporting & communication, and clinical decision support across CT, MRI, ultrasound, and mammography. This trend is improving diagnostic turnaround time, reducing missed findings, lowering radiologist workload, and increasing consistency across image interpretation workflows. AI-based triage, automated lesion detection, deep learning reconstruction, and cloud-enabled enterprise imaging are changing how healthcare organizations manage diagnostic operations. In December 2024, the FDA finalized guidance on Predetermined Change Control Plans, letting AI software makers pre-authorize future updates instead of filing new submissions each time. Major players such as Siemens Healthineers AG, GE HealthCare, Koninklijke Philips N.V., Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, and Aidoc Medical Ltd. are contributing to this shift through AI-enabled hardware integration, cloud platforms, strategic acquisitions, and vendor-neutral algorithm marketplaces.

medical-image-analysis-software-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Rising imaging volumes amid growing radiologist workforce shortages
  • Increasing FDA and regulatory clearances for AI-enabled imaging software
RESTRAINTS
Impact
Level
  • High cost of software validation, integration, and deployment
  • Data privacy and cross-border health data regulations
OPPORTUNITIES
Impact
Level
  • Expansion of cloud-native and AI-as-a-service imaging platforms
  • Emerging applications of foundation models and multimodal AI in diagnostic imaging
CHALLENGES
Impact
Level
  • Limited interoperability with legacy PACS/RIS and vendor-specific systems
  • Algorithm generalizability and bias across diverse patient populations

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising imaging volumes amid growing radiologist workforce shortages

According to the American Journal of Roentgenology, US imaging volume is rising by roughly 5% annually, while the American College of Radiology recorded 1,900 radiology job postings in January 2025 alone. Only about 1,000 new radiologists enter the US workforce each year, well short of demand. This imbalance is forcing hospitals to rely on AI software to triage, prioritize, and pre-screen scans before radiologist review. The gap is even wider in emerging markets, where rural regions often have fewer than one radiologist per 100,000 people. As imaging demand keeps outpacing radiologist supply, AI-enabled detection and workflow software is becoming essential rather than optional.

Restraint: High cost of software validation, integration, and deployment

Clinically validating AI algorithms against diverse patient populations requires large annotated datasets and multi-site studies, which is expensive and time-consuming. Integrating new AI tools with existing PACS/RIS infrastructure often requires custom IT work and ongoing technical support. Smaller hospitals and diagnostic centers frequently lack the budget or in-house IT staff to manage this integration burden. Total cost of ownership includes not just licensing fees but also validation, training, and workflow redesign. These costs can slow or block adoption, particularly outside large, well-funded hospital systems.

Opportunity: Expansion of cloud-native and AI-as-a-service imaging platforms

Cloud-based deployment models are lowering the upfront cost barrier for hospitals to access AI imaging tools without large on-premises infrastructure investment. Vendor-neutral platforms are allowing hospitals to run multiple AI algorithms from different companies on a single infrastructure layer. This model supports faster scaling across multi-site hospital networks and teleradiology providers. Subscription-based pricing is also making advanced AI tools more accessible to smaller diagnostic centers. As cloud infrastructure matures, AI-as-a-service is expected to become a preferred deployment model over traditional on-premises software.

Challenge: Limited interoperability with legacy PACS/RIS and vendor-specific systems

Many hospitals still operate on older PACS/RIS systems that were not designed to integrate with modern AI software. Vendor-specific data formats and proprietary architectures make it difficult to deploy AI tools across multi-vendor imaging environments. This fragmentation forces hospitals to either limit AI adoption to compatible systems or invest in costly infrastructure upgrades. Enterprise imaging vendors are working to build more open, vendor-neutral platforms, but full interoperability remains uneven across the industry. Until legacy system compatibility improves, this remains a practical barrier to widescale AI deployment.

MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Provides an AI-enabled radiology services suite covering scheduling, image acquisition, and automated reporting Reduces reporting time and improves consistency of image interpretation
company logo
Combines its AI imaging portfolio with Intelerad's cloud and AI orchestration capabilities to deliver connected imaging software across care settings Expands cloud-enabled imaging access and improves radiology workflow efficiency
company logo
Offers Philips Verida, the world's first detector-based Spectral CT fully powered by AI, and Philips Vue PACS, a web-based diagnostic viewer Improves diagnostic image quality and enables remote study access without dedicated software
company logo
Provides Precise IQ Engine, an AI deep learning reconstruction technology under its Altivity AI brand for high-resolution CT imaging Improves image resolution at lower radiation dose and standardizes imaging protocols
company logo
Offers REiLI, a vendor-neutral AI platform integrated into Synapse PACS that hosts both Fujifilm and third-party AI algorithms Lets hospitals run multiple vendors' AI tools on one platform, speeding up reporting

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The medical image analysis software ecosystem includes imaging equipment manufacturers, AI software vendors, hospitals and diagnostic imaging centers, academic and research institutions, PACS/RIS and IT integration partners, cloud service providers, and regulatory/compliance bodies. Imaging equipment manufacturers help healthcare organizations combine hardware and AI software for detection & localization, segmentation & analysis, reconstruction & visualization, registration & comparison, and reporting & communication across CT, MRI, ultrasound, and mammography. Hospitals use image analysis software to reduce radiologist workload, improve diagnostic turnaround time, and support clinical decision-making across cardiology, oncology, and neurology. Diagnostic imaging centers use AI-based triage and reporting tools to manage high patient volumes and support remote and teleradiology reading models. Academic and research institutions use imaging AI software for multi-center clinical studies and disease-specific research as imaging datasets grow larger. AI and cloud technology vendors support the ecosystem by enabling deep learning algorithms, vendor-neutral AI platforms, cloud-native deployment, and workflow automation. Regulatory bodies such as the FDA, EMA, and China's NMPA shape the ecosystem through device clearance pathways, AI update frameworks, and data privacy requirements that govern how imaging software reaches clinical use.

medical-image-analysis-software-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

medical-image-analysis-software-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Medical Image Analysis Software Market, by Type

The integrated software segment held the largest share of the medical image analysis software market in 2025, as imaging equipment manufacturers such as Siemens Healthineers AG and Koninklijke Philips N.V. increasingly bundle AI directly into CT, MRI, and X-ray systems. Hospitals prefer integrated software because it eliminates separate installation, licensing, and vendor management. The segment remains largest because equipment makers use bundled AI to strengthen customer retention and build recurring software revenue. Standalone software, offered by vendor-neutral AI companies, is expected to grow steadily as hospitals seek algorithms that work across multiple scanner brands.

Medical Image Analysis Software Market, by Technology

During the forecast period, AI-enabled technology is expected to grow the fastest, as healthcare providers seek to automate image interpretation and manage rising imaging volumes. Deep learning, computer vision, and machine learning are increasingly incorporated into software for automated analysis, abnormality detection, and quantitative assessment. AI-based tools can reduce repetitive tasks for radiologists, improve workflow efficiency, and support faster interpretation of complex imaging studies. The increasing availability of AI-enabled solutions for early disease detection, image segmentation, triage, and clinical decision support is further supporting adoption

Medical Image Analysis Software Market, by Function

The reconstruction & visualization segment held the largest share of the medical image analysis software market in 2025, as radiology departments rely heavily on tools that improve image clarity and reduce radiation dose during CT and MRI scans. Detection & localization is expected to register the fastest growth during the forecast period. This is because AI-based detection tools directly address radiologist shortages by flagging urgent findings for priority review. As hospitals prioritize faster triage of critical cases, detection & localization software is becoming a leading area of adoption.

Medical Image Analysis Software Market, by Image Type

During the forecast period, the 4D imaging segment is expected to register the fastest growth, driven by the increasing adoption of dynamic, time-resolved imaging for more comprehensive visualization and quantitative analysis of anatomical structures and physiological processes. The growing use of 4D imaging in cardiac MRI, 4D flow MRI, and 3D/4D ultrasound is further supporting segment growth, particularly for cardiovascular assessment and functional analysis. In addition, the availability of advanced software solutions for 4D visualization, segmentation, flow quantification, and automated analysis is improving the clinical utility of 4D imaging.

Medical Image Analysis Software Market, by Modality

During the forecast period, ultrasound imaging is expected to experience the fastest growth, supported by the increasing use of AI-assisted ultrasound for image acquisition, optimization, measurement, and interpretation. AI-enabled ultrasound technologies can assist clinicians with standardized imaging and automated assessment, expanding the role of software in point-of-care and diagnostic workflows.

Medical Image Analysis Software Market, by Therapeutic Area

The cardiology segment held the largest share of the market in 2025, as AI-based CT and echocardiography analysis tools are widely used for coronary artery disease detection and cardiac risk assessment. Oncology is expected to register the fastest growth during the forecast period. Oncology is growing quickly because AI-based tumor detection, measurement, and treatment-response tracking support earlier cancer diagnosis and more precise treatment planning. As cancer incidence rises globally, oncology imaging software is becoming a major area of vendor investment.

Medical Image Analysis Software Market, by End User

During the forecast period, diagnostic imaging centers are expected to experience the fastest growth, supported by rising imaging volumes, demand for faster reporting, and increasing adoption of AI-assisted analysis. Automated detection, segmentation, quantification, and workflow tools can help imaging centers manage high case volumes and improve operational efficiency. The growing use of outpatient imaging and specialized diagnostic services is increasing the need for scalable image analysis solutions. AI-enabled tools can also help standardize image interpretation, prioritize critical cases, and reduce turnaround times for diagnostic reports.

REGION

Asia Pacific region is expected to register the fastest growth in the medical image analysis software market during the forecast period

The Asia Pacific market is anticipated to grow at the fastest CAGR during the forecast period, supported by rapid healthcare digitization, increasing diagnostic imaging volumes, expanding healthcare infrastructure, and growing adoption of AI-enabled medical technologies. Countries such as China, Japan, India, South Korea, and Australia are increasing the use of AI-assisted imaging for detection, image analysis, clinical decision support, and workflow automation. In November 2025, China’s National Health Commission issued guidance supporting AI applications in medical imaging, including assisted diagnosis, automated reporting, image-quality evaluation, and treatment recommendations, with broader adoption targeted across secondary and tertiary hospitals by 2030. In January 2026, FUJIFILM India introduced AI-enabled CT, mammography, radiography, and healthcare IT solutions to help radiology departments manage rising imaging volumes and diagnostic complexity.

medical-image-analysis-software-market Region

MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: COMPANY EVALUATION MATRIX

In the medical image analysis software market matrix, Siemens Healthineers AG (Star) leads with its strong portfolio of AI-enabled imaging and clinical decision-support solutions, including AI-Rad Companion across CT, MRI, and X-ray applications. Its deep integration of AI into imaging workflows, automated segmentation and measurements, and broad installed base of imaging systems strengthen its position in the market. Microsoft Corporation (Emerging Leader) is gaining traction through its healthcare AI ecosystem, including MedImageInsight and MedImageParse for medical image embeddings, segmentation, detection, and multimodal analysis.

medical-image-analysis-software-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 4.04 Billion
Market Size in 2026 (Value) USD 4.35 Billion
Market Forecast in 2031 (Value) USD 6.42 Billion
CAGR CAGR of 8.1% from 2026–2031
Years Considered 2024–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered Value (USD Billion)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered By Type [Integrated Software, Standalone Software], Technology [AI-enabled Technology {Machine Learning, Deep Learning, Computer Vision, Natural Language Processing}, Conventional Technology], Function [Reconstruction & Visualization, Detection & Localization, Segmentation & Analysis, Registration & Comparison, Reporting & Communication, Clinical Decision Support], Image Type [2D Imaging, 3D Imaging, 4D Imaging], Modality [Radiography (X-ray), Computed Tomography (CT) {High-end Slice CT, Mid-end Slice CT, Low-end Slice CT}, Magnetic Resonance Imaging (MRI) {Closed MRI Systems, Open MRI Systems}, Ultrasound Imaging {2D Ultrasound Systems, 3D and 4D Ultrasound Systems, Doppler Imaging}, Nuclear Imaging {Positron Emission Tomography (PET), Single-photon Emission Computed Tomography (SPECT)}, Mammography, Combined/Hybrid Modalities {PET/CT, SPECT/CT, PET/MR}, Others], Therapeutic Area [Cardiology, Oncology, Neurology, Orthopedics, Dental, Obstetrics & Gynecology, Mammography/Breast Imaging, Others], End User [Hospitals, Diagnostic Imaging Centers, Academic & Research Institutions, Other End Users]
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa

WHAT IS IN IT FOR YOU: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET REPORT CONTENT GUIDE

medical-image-analysis-software-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Medical Image Analysis Software Market – AI-enabled Image Analysis & Clinical Workflow
  • Developed a customization focused on how AI-enabled image analysis is transforming radiology workflows
  • Covered automated detection, segmentation, quantitative analysis, reconstruction, visualization, and clinical decision support
  • Mapped key players such as Siemens Healthineers, GE HealthCare, Philips, Microsoft, Aidoc, and RapidAI
  • Helped identify AI-enabled image analysis as a major technology opportunity beyond conventional image processing
  • Provided visibility into how deep learning and automated analysis can reduce repetitive tasks, support faster interpretation, and improve diagnostic workflows
  • Supported stronger understanding of how AI solutions are being integrated with existing imaging and reporting environments
Medical Image Analysis Software Market – Integrated Imaging & AI Workflow Strategy
  • Built a workflow-focused view covering integrated imaging software, AI-powered post-processing, PACS integration, automated measurements, structured reporting, and multimodality analysis
  • Assessed how vendors are embedding AI into existing imaging ecosystems
  • Helped clients understand where integration, automation, and AI adoption can create the strongest value across medical imaging workflows
  • Provided insight into reducing manual image-processing activities, improving radiologist productivity, and supporting scalable deployment across imaging environments
  • Supported better vendor benchmarking by comparing integrated platforms with specialized AI image-analysis solutions

RECENT DEVELOPMENTS

  • July 2026 : GE HealthCare introduced MIM Anyware, a browser-based remote-access platform providing secure access to its portfolio of MIM software solutions for imaging data review and processing. The platform enables authorized users to access and process imaging data from virtually any location and supports simultaneous clinical review across departments, directly representing a substantive development in medical image analysis software.
  • July 2026 : Canon Medical Systems Corporation introduced CLEAR Motion across its Aquilion ONE premium CT portfolio and expanded availability of PIQE 1024 Matrix Deep Learning Reconstruction. CLEAR Motion applies deep-learning motion correction to raw CT projection data, while PIQE 1024 generates super-resolution images from ultra-high-resolution data, providing direct image-analysis and reconstruction capabilities for complex clinical imaging.
  • May 2026 : Siemens Healthineers received the CE mark for AI Contouring for Eclipse, an AI-enabled software capability that automatically contours more than 200 predefined structures from CT and MR images for radiation-therapy planning. The software is integrated into the Varian Eclipse treatment-planning workflow and directly analyzes medical images to automate contouring, making it a strong qualifying development for the keyword.
  • June 2026 : Aidoc Medical Ltd. (Israel) received FDA Breakthrough Device Designation for First Read, an AI solution designed to analyze chest X-rays and generate preliminary radiology report text. The development extends Aidoc’s clinical AI platform into report drafting to address rising imaging volumes and radiologist workload.
  • November 2025 : Siemens Healthineers AG (Germany) introduced new AI-enabled radiology services spanning scheduling, image acquisition, and reporting. The solutions use AI to summarize clinically relevant observations and reduce manual annotation and reporting tasks, strengthening the company’s integrated imaging workflow capabilities.

 

Table of Contents

checkmarkExclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
42
2
EXECUTIVE SUMMARY
 
 
 
 
 
48
3
PREMIUM INSIGHTS
 
 
 
 
 
54
4
MARKET OVERVIEW
AI-driven imaging innovations tackle workforce shortages, regulatory hurdles, and unlock new diagnostic potentials.
 
 
 
 
 
56
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
RISING IMAGING VOLUMES AMID GROWING RADIOLOGIST WORKFORCE SHORTAGES
 
 
 
 
 
 
4.2.1.2
INCREASING FDA AND REGULATORY CLEARANCES FOR AI-ENABLED IMAGING SOFTWARE
 
 
 
 
 
 
4.2.1.3
GROWING DEMAND FOR EARLY AND ACCURATE DISEASE DETECTION
 
 
 
 
 
 
4.2.1.4
INCREASING ADOPTION OF QUANTITATIVE AND WORKFLOW-AUTOMATION SOLUTIONS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
HIGH COST OF SOFTWARE VALIDATION, INTEGRATION, AND DEPLOYMENT
 
 
 
 
 
 
4.2.2.2
DATA PRIVACY AND CROSS-BORDER HEALTH DATA REGULATIONS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
EXPANSION OF CLOUD-NATIVE AND AI-AS-A-SERVICE IMAGING PLATFORMS
 
 
 
 
 
 
4.2.3.2
EMERGING APPLICATIONS OF FOUNDATION MODELS AND MULTIMODAL AI IN DIAGNOSTIC IMAGING
 
 
 
 
 
 
4.2.3.3
EXPANSION INTO NEW IMAGING MODALITIES AND CLINICAL SPECIALTIES
 
 
 
 
 
 
4.2.3.4
INTEGRATION OF IMAGE ANALYSIS WITH CLINICAL DECISION-SUPPORT AND LONGITUDINAL CARE PLATFORMS
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
LIMITED INTEROPERABILITY WITH LEGACY PACS/RIS AND VENDOR-SPECIFIC SYSTEMS
 
 
 
 
 
 
4.2.4.2
ALGORITHM GENERALIZABILITY AND BIAS ACROSS DIVERSE PATIENT POPULATIONS
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
5
INDUSTRY TRENDS
Leverage AI-driven innovations to navigate competitive pressures and optimize pricing in medical imaging.
 
 
 
 
 
67
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.2
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.3
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.4
THREAT OF NEW ENTRANTS
 
 
 
 
 
 
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
5.2
MACROECONOMIC INDICATORS
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
 
 
5.2.3
TRENDS IN GLOBAL HEALTHCARE INDUSTRY
 
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
 
5.3.1
RESEARCH, IMAGING DATA GENERATION, AND CLINICAL INPUTS
 
 
 
 
 
 
5.3.2
DATA ENGINEERING & AI INFRASTRUCTURE
 
 
 
 
 
 
5.3.3
AI MODEL & PLATFORM DEVELOPMENT
 
 
 
 
 
 
5.3.4
WORKFLOW INTEGRATION & INTEROPERABILITY
 
 
 
 
 
 
5.3.5
SOFTWARE DEPLOYMENT & CLINICAL SERVICES
 
 
 
 
 
 
5.3.6
CLINICAL VALIDATION, MONITORING, AND CONTINUOUS OPTIMIZATION
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
MEDICAL IMAGE ANALYSIS SOFTWARE PLATFORMS, BY KEY PLAYERS (2025)
 
 
 
 
 
 
5.5.2
INDICATIVE PRICE FOR MEDICAL IMAGE ANALYSIS SOFTWARE, BY REGION (2025)
 
 
 
 
 
5.6
KEY CONFERENCES AND EVENTS, 2026–2027
 
 
 
 
 
 
5.7
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
 
5.8
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
 
 
5.9
CASE STUDY ANALYSIS
 
 
 
 
 
 
5.10
IMPACT OF 2025 US TARIFF – MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
 
 
 
 
 
 
 
 
5.10.1
INTRODUCTION
 
 
 
 
 
 
5.10.2
KEY TARIFF RATES
 
 
 
 
 
 
5.10.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.10.4
IMPACT ON COUNTRY/REGION
 
 
 
 
 
 
 
5.10.4.1
US
 
 
 
 
 
 
5.10.4.2
EUROPE
 
 
 
 
 
 
5.10.4.3
ASIA PACIFIC
 
 
 
 
 
5.10.5
IMPACT ON END USERS
 
 
 
 
 
 
 
5.10.5.1
HOSPITALS AND HEALTH SYSTEMS
 
 
 
 
 
 
5.10.5.2
DIAGNOSTIC IMAGING CENTERS
 
 
 
 
 
 
5.10.5.3
SPECIALTY CLINICS AND AMBULATORY CARE PROVIDERS
 
 
 
 
 
 
5.10.5.4
PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
5.10.5.5
ACADEMIC AND RESEARCH INSTITUTIONS
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven innovations redefine medical imaging with personalized, early detection and seamless data integration.
 
 
 
 
 
89
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1
AI-POWERED DEEP LEARNING AND FOUNDATION MODELS
 
 
 
 
 
 
6.1.2
CLOUD-NATIVE MEDICAL IMAGING AND AI-AS-A-SERVICE
 
 
 
 
 
 
 
ADVANCED 3D VISUALIZATION, SEGMENTATION, AND
 
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
6.2.1
CLOUD COMPUTING AND EDGE COMPUTING
 
 
 
 
 
 
6.2.2
INTEROPERABILITY, PACS/VNA, AND CLINICAL DATA INTEGRATION
 
 
 
 
 
6.3
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
6.4
PATENT ANALYSIS
 
 
 
 
 
 
 
 
6.4.1
PATENT PUBLICATION TRENDS FOR MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
 
 
 
 
 
 
6.4.2
INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
 
 
 
 
 
6.5
FUTURE APPLICATIONS
 
 
 
 
 
 
 
6.5.1
EARLY DISEASE DETECTION AND SCREENING
 
 
 
 
 
 
6.5.2
PERSONALIZED TREATMENT PLANNING AND THERAPY GUIDANCE
 
 
 
 
 
 
6.5.3
LONGITUDINAL DISEASE MONITORING AND TREATMENT RESPONSE
 
 
 
 
 
6.6
IMPACT OF AI/GEN AI ON MEDICAL IMAGE ANALYSIS SOFTWARE SOLUTIONS
 
 
 
 
 
 
 
 
6.6.1
INTRODUCTION
 
 
 
 
 
 
6.6.2
CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
 
 
 
 
 
 
 
6.6.2.1
AI-POWERED CHEST X-RAY ANALYSIS FOR TUBERCULOSIS SCREENING
 
 
 
 
 
6.6.3
IMPACT OF AI/GEN AI ON INTERCONNECTED & ADJACENT ECOSYSTEMS
 
 
 
 
 
 
 
6.6.3.1
PACS/VNA & ENTERPRISE IMAGING MARKET
 
 
 
 
 
 
6.6.3.2
AI IN MEDICAL IMAGING MARKET
 
 
 
 
 
 
6.6.3.3
EHR/CLINICAL DECISION SUPPORT MARKET
 
 
 
 
 
6.6.4
USER READINESS & IMPACT ASSESSMENT
 
 
 
 
 
 
 
6.6.4.1
USER READINESS
 
 
 
 
 
 
 
 
6.6.4.1.1
USER A: HEALTHCARE PROVIDERS
 
 
 
 
 
 
6.6.4.1.2
USER B: DIAGNOSTIC IMAGING CENTERS
 
 
 
 
6.6.4.2
IMPACT ASSESSMENT
 
 
 
 
 
 
 
 
6.6.4.2.1
USER A: HEALTHCARE PROVIDERS
 
 
 
 
 
 
6.6.4.2.2
USER B: DIAGNOSTIC IMAGING CENTERS
 
7
REGULATORY LANDSCAPE
Navigate complex global regulations with region-specific insights for strategic compliance advantage.
 
 
 
 
 
106
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
7.1.2
REGULATORY FRAMEWORK
 
 
 
 
 
 
 
7.1.2.1
NORTH AMERICA
 
 
 
 
 
 
7.1.2.2
EUROPE
 
 
 
 
 
 
7.1.2.3
ASIA PACIFIC
 
 
 
 
 
 
7.1.2.4
LATIN AMERICA
 
 
 
 
 
 
7.1.2.5
MIDDLE EAST & AFRICA
 
 
 
 
 
7.1.3
INDUSTRY STANDARDS
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock strategic insights into decision-making and unmet needs shaping buyer behavior in key markets.
 
 
 
 
 
119
 
8.1
INTRODUCTION
 
 
 
 
 
 
8.2
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.3
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
 
 
 
8.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.3.2
BUYING CRITERIA
 
 
 
 
 
8.4
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
8.5
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
 
 
8.5.1
UNMET NEEDS
 
 
 
 
 
 
8.5.2
END USER EXPECTATIONS
 
 
 
 
 
8.6
MARKET PROFITABILITY
 
 
 
 
 
9
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 5 Data Tables
 
 
 
 
 
126
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
HOSPITALS
 
 
 
 
 
 
 
9.2.1
INCREASING ADOPTION OF ADVANCED MEDICAL IMAGING AND AI IN HOSPITALS
 
 
 
 
 
9.3
DIAGNOSTIC IMAGING CENTERS
 
 
 
 
 
 
 
9.3.1
RISING DEMAND FOR EFFICIENT AND HIGH-VOLUME DIAGNOSTIC IMAGING TO BOOST MARKET
 
 
 
 
 
9.4
ACADEMIC & RESEARCH INSTITUTIONS
 
 
 
 
 
 
 
9.4.1
INCREASING USE OF MEDICAL IMAGE ANALYSIS SOFTWARE IN RESEARCH TO BOOST SEGMENT
 
 
 
 
 
9.5
OTHER END USERS
 
 
 
 
 
 
 
9.5.1
EXPANDING USE OF MEDICAL IMAGE ANALYSIS BEYOND CONVENTIONAL HEALTHCARE SETTING TO BOOST SEGMENT
 
 
 
 
10
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 7 Data Tables
 
 
 
 
 
132
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
RECONSTRUCTION & VISUALIZATION
 
 
 
 
 
 
 
10.2.1
INCREASING DEMAND FOR HIGH-QUALITY IMAGE RECONSTRUCTION AND 3D VISUALIZATION TO BOOST SEGMENT
 
 
 
 
 
10.3
DETECTION & LOCALIZATION
 
 
 
 
 
 
 
10.3.1
RISING DEMAND FOR AUTOMATED DETECTION AND LOCALIZATION OF ABNORMALITIES
 
 
 
 
 
10.4
SEGMENTATION & ANALYSIS
 
 
 
 
 
 
 
10.4.1
INCREASING ADOPTION OF AUTOMATED SEGMENTATION AND QUANTITATIVE IMAGE ANALYSIS
 
 
 
 
 
10.5
REGISTRATION & COMPARISON
 
 
 
 
 
 
 
10.5.1
GROWING NEED FOR ACCURATE ALIGNMENT AND COMPARISON OF MULTIMODAL MEDICAL IMAGES TO BOOST GROWTH
 
 
 
 
 
10.6
REPORTING & COMMUNICATION
 
 
 
 
 
 
 
10.6.1
GROWING ADOPTION OF AI-POWERED RADIOLOGY REPORTING AND WORKFLOW AUTOMATION TO DRIVE SEGMENT
 
 
 
 
 
10.7
CLINICAL DECISION SUPPORT
 
 
 
 
 
 
 
10.7.1
INCREASING ADOPTION OF AI-ASSISTED CLINICAL DECISION SUPPORT
 
 
 
 
11
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 4 Data Tables
 
 
 
 
 
140
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
3D IMAGING
 
 
 
 
 
 
 
11.2.1
GROWING ADOPTION OF 3D IMAGING FOR DETAILED ANATOMICAL VISUALIZATION TO BOOST SEGMENT
 
 
 
 
 
11.3
4D IMAGING
 
 
 
 
 
 
 
11.3.1
GROWING DEMAND FOR DYNAMIC AND FUNCTIONAL MEDICAL IMAGING TO DRIVE SEGMENT
 
 
 
 
 
11.4
2D IMAGING
 
 
 
 
 
 
 
11.4.1
CONTINUED DEMAND FOR 2D IMAGING IN ROUTINE DIAGNOSTIC APPLICATIONS – KEY DRIVER
 
 
 
 
12
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 27 Data Tables
 
 
 
 
 
144
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
RADIOGRAPHY (X-RAY)
 
 
 
 
 
 
 
12.2.1
INCREASING ADOPTION OF AI-ENABLED X-RAY ANALYSIS AND WORKFLOW AUTOMATION TO DRIVE SEGMENT
 
 
 
 
 
12.3
COMPUTED TOMOGRAPHY (CT)
 
 
 
 
 
 
 
12.3.1
SEGMENT DRIVEN BY AI-ENABLED CT IMAGE ANALYSIS FOR RECONSTRUCTION AND DETECTION
 
 
 
 
 
 
12.3.2
HIGH-END SLICE CT
 
 
 
 
 
 
 
12.3.2.1
GROWING DEMAND FOR HIGH-RESOLUTION AND ADVANCED CT IMAGING – KEY DRIVER
 
 
 
 
 
12.3.3
MID-END SLICE CT
 
 
 
 
 
 
 
12.3.3.1
DEMAND FOR VERSATILE CT SYSTEMS WITH AUTOMATED ANALYSIS TO BOOST GROWTH
 
 
 
 
 
12.3.4
LOW-END SLICE CT
 
 
 
 
 
 
 
12.3.4.1
EXPANDING ACCESS TO COST-EFFICIENT CT IMAGING TO PROPEL GROWTH
 
 
 
 
12.4
MAGNETIC RESONANCE IMAGING (MRI)
 
 
 
 
 
 
 
12.4.1
INCREASING ADOPTION OF AI-POWERED MRI RECONSTRUCTION AND WORKFLOW AUTOMATION TO DRIVE MARKET
 
 
 
 
 
 
12.4.2
CLOSED MRI SYSTEMS
 
 
 
 
 
 
 
12.4.2.1
INCREASING DEMAND FOR HIGH-RESOLUTION AND AI-OPTIMIZED MRI TO DRIVE SEGMENT
 
 
 
 
 
12.4.3
OPEN MRI SYSTEMS
 
 
 
 
 
 
 
12.4.3.1
EXPANDING ACCESS TO PATIENT-FRIENDLY AND SPECIALIZED MRI TO DRIVE SEGMENT
 
 
 
 
12.5
ULTRASOUND IMAGING
 
 
 
 
 
 
 
 
INCREASING ADOPTION OF AI-POWERED ULTRASOUND IMAGING
 
 
 
 
 
 
12.5.2
2D ULTRASOUND SYSTEMS
 
 
 
 
 
 
 
12.5.2.1
EXPANDING USE OF AI-ASSISTED ANALYSIS IN ROUTINE 2D ULTRASOUND TO DRIVE SEGMENT
 
 
 
 
 
12.5.3
3D & 4D ULTRASOUND SYSTEMS
 
 
 
 
 
 
 
12.5.3.1
INCREASING DEMAND FOR VOLUMETRIC AND DYNAMIC ULTRASOUND ANALYSIS TO BOOST SEGMENT
 
 
 
 
 
12.5.4
DOPPLER IMAGING
 
 
 
 
 
 
 
12.5.4.1
GROWING DEMAND FOR AUTOMATED BLOOD-FLOW ASSESSMENT
 
 
 
 
12.6
NUCLEAR IMAGING
 
 
 
 
 
 
 
12.6.1
GROWING ADOPTION OF QUANTITATIVE ANALYSIS IN NUCLEAR IMAGING TO BOOST SEGMENT
 
 
 
 
 
 
12.6.2
POSITRON EMISSION TOMOGRAPHY (PET)
 
 
 
 
 
 
 
12.6.2.1
INCREASING USE OF QUANTITATIVE PET FOR MOLECULAR AND FUNCTIONAL IMAGING TO DRIVE SEGMENT
 
 
 
 
 
12.6.3
SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT)
 
 
 
 
 
 
 
12.6.3.1
GROWING DEMAND FOR QUANTITATIVE SPECT IN THERANOSTICS AND CARDIOVASCULAR IMAGING
 
 
 
 
12.7
MAMMOGRAPHY
 
 
 
 
 
 
 
12.7.1
INCREASING ADOPTION OF AI-POWERED MAMMOGRAPHY FOR BREAST CANCER DETECTION TO BOOS SEGMENT
 
 
 
 
 
12.8
COMBINED/HYBRID MODALITIES
 
 
 
 
 
 
 
12.8.1
GROWING ADOPTION OF HYBRID IMAGING FOR INTEGRATED ANATOMICAL AND FUNCTIONAL ANALYSIS TO BOOST SEGMENT
 
 
 
 
 
 
12.8.2
PET/CT
 
 
 
 
 
 
 
12.8.2.1
INCREASING DEMAND FOR QUANTITATIVE PET/CT IN ONCOLOGY
 
 
 
 
 
12.8.3
SPECT/CT
 
 
 
 
 
 
 
12.8.3.1
INCREASING USE OF SPECT/CT FOR QUANTITATIVE ASSESSMENT AND DOSIMETRY
 
 
 
 
 
12.8.4
PET/MR
 
 
 
 
 
 
 
 
GROWING DEMAND FOR HIGH-RESOLUTION MULTIMODAL BRAIN AND
 
 
 
 
12.9
OTHERS
 
 
 
 
 
13
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 8 Data Tables
 
 
 
 
 
167
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
AI-ENABLED TECHNOLOGY
 
 
 
 
 
 
 
13.2.1
INCREASING ADOPTION OF AI FOR AUTOMATED AND QUANTITATIVE IMAGE ANALYSIS
 
 
 
 
 
 
13.2.2
MACHINE LEARNING
 
 
 
 
 
 
 
13.2.2.1
INCREASING USE OF MACHINE LEARNING FOR AUTOMATED MEDICAL IMAGE ANALYSIS TO DRIVE SEGMENT
 
 
 
 
 
13.2.3
DEEP LEARNING
 
 
 
 
 
 
 
13.2.3.1
GROWING USE OF DEEP LEARNING FOR HIGH-PRECISION MEDICAL IMAGE RECONSTRUCTION AND ANALYSIS TO BOOST SEGMENT
 
 
 
 
 
13.2.4
COMPUTER VISION
 
 
 
 
 
 
 
13.2.4.1
INCREASING ADOPTION OF COMPUTER VISION FOR AUTOMATED DETECTION AND INTERPRETATION OF MEDICAL IMAGES TO BOOST SEGMENT
 
 
 
 
 
13.2.5
NATURAL LANGUAGE PROCESSING (NLP)
 
 
 
 
 
 
 
13.2.5.1
INCREASING USE OF NLP FOR AUTOMATED RADIOLOGY REPORTING AND CLINICAL INFORMATION EXTRACTION
 
 
 
 
13.3
CONVENTIONAL TECHNOLOGY
 
 
 
 
 
 
 
13.3.1
CONTINUED DEMAND FOR RELIABLE AND ESTABLISHED IMAGE PROCESSING
 
 
 
 
14
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 9 Data Tables
 
 
 
 
 
175
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
CARDIOLOGY
 
 
 
 
 
 
 
14.2.1
INCREASING ADOPTION OF AI-POWERED CARDIOVASCULAR IMAGE ANALYSIS TO DRIVE MARKET
 
 
 
 
 
14.3
ONCOLOGY
 
 
 
 
 
 
 
14.3.1
INCREASING USE OF MEDICAL IMAGING AND AI FOR CANCER DETECTION AND TREATMENT MONITORING TO BOOST SEGMENT
 
 
 
 
 
14.4
NEUROLOGY
 
 
 
 
 
 
 
14.4.1
RISING DEMAND FOR AI-ASSISTED NEUROLOGICAL IMAGING AND EARLY DISEASE DETECTION
 
 
 
 
 
14.5
ORTHOPEDICS
 
 
 
 
 
 
 
14.5.1
GROWING ADOPTION OF AI-ENABLED IMAGING FOR ORTHOPEDIC DIAGNOSIS AND SURGICAL PLANNING
 
 
 
 
 
14.6
DENTAL
 
 
 
 
 
 
 
14.6.1
INCREASING ADOPTION OF AI-ENABLED DENTAL IMAGING AND DIAGNOSTIC ANALYSIS TO BOOST SEGMENT
 
 
 
 
 
14.7
OBSTETRICS & GYNECOLOGY
 
 
 
 
 
 
 
14.7.1
INCREASING ADOPTION OF AI-ENABLED OBSTETRIC AND GYNECOLOGICAL IMAGING
 
 
 
 
 
14.8
MAMMOGRAPHY/BREAST IMAGING
 
 
 
 
 
 
 
14.8.1
GROWING ADOPTION OF AI FOR BREAST CANCER DETECTION AND MAMMOGRAPHY WORKFLOW OPTIMIZATION
 
 
 
 
 
14.9
OTHER THERAPEUTIC AREAS
 
 
 
 
 
 
 
14.9.1
EXPANDING APPLICATIONS OF MEDICAL IMAGE ANALYSIS ACROSS EMERGING THERAPEUTIC AREAS
 
 
 
 
15
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 3 Data Tables
 
 
 
 
 
185
 
15.1
INTRODUCTION
 
 
 
 
 
 
15.2
INTEGRATED SOFTWARE
 
 
 
 
 
 
 
15.2.1
GROWING INTEGRATION OF AI-POWERED IMAGE ANALYSIS INTO CLINICAL WORKFLOWS TO BOOST SEGMENT
 
 
 
 
 
15.3
STANDALONE SOFTWARE
 
 
 
 
 
 
 
15.3.1
INCREASING ADOPTION OF AI-ENABLED STANDALONE IMAGE ANALYSIS SOLUTIONS TO DRIVE SEGMENT
 
 
 
 
16
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 17 Countries | 371 Data Tables.
 
 
 
 
 
189
 
16.1
INTRODUCTION
 
 
 
 
 
 
16.2
NORTH AMERICA
 
 
 
 
 
 
 
16.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
 
 
16.2.2
US
 
 
 
 
 
 
 
16.2.2.1
GROWING DEMAND FOR FASTER DIAGNOSTICS TO BOOST DEMAND
 
 
 
 
 
16.2.3
CANADA
 
 
 
 
 
 
 
16.2.3.1
INCREASING INVESTMENTS IN HEALTHCARE DATA INFRASTRUCTURE AND MEDICAL IMAGING AI TO DRIVE MARKET
 
 
 
 
16.3
EUROPE
 
 
 
 
 
 
 
16.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
 
 
16.3.2
GERMANY
 
 
 
 
 
 
 
16.3.2.1
GROWING ADOPTION OF AI-POWERED MEDICAL IMAGING AND RADIOLOGY SOLUTIONS TO DRIVE MARKET
 
 
 
 
 
16.3.3
FRANCE
 
 
 
 
 
 
 
16.3.3.1
INCREASING ADOPTION OF AI-BASED MEDICAL IMAGING SOLUTIONS TO DRIVE MARKET
 
 
 
 
 
16.3.4
UK
 
 
 
 
 
 
 
16.3.4.1
INCREASING GOVERNMENT SUPPORT FOR AI-ENABLED MEDICAL IMAGING TO BOOST MARKET
 
 
 
 
 
16.3.5
ITALY
 
 
 
 
 
 
 
16.3.5.1
GROWING ADOPTION OF AI IN MEDICAL IMAGING AND DIAGNOSTIC WORKFLOWS TO BOOST MARKET
 
 
 
 
 
16.3.6
SPAIN
 
 
 
 
 
 
 
16.3.6.1
EXPANDING ADOPTION OF AI-POWERED MEDICAL IMAGING SOLUTIONS TO BOOST MARKET
 
 
 
 
 
16.3.7
REST OF EUROPE
 
 
 
 
 
16.4
ASIA PACIFIC
 
 
 
 
 
 
 
16.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
 
 
16.4.2
CHINA
 
 
 
 
 
 
 
16.4.2.1
EXPANDING DEPLOYMENT OF AI-POWERED MEDICAL IMAGING SOLUTIONS TO BOOST MARKET
 
 
 
 
 
16.4.3
JAPAN
 
 
 
 
 
 
 
16.4.3.1
GROWING ADOPTION OF AI IN MEDICAL IMAGING AND RADIOLOGY TO BOOST MARKET
 
 
 
 
 
16.4.4
INDIA
 
 
 
 
 
 
 
16.4.4.1
INCREASING INVESTMENT IN AI-POWERED MEDICAL IMAGING AND DIAGNOSTIC INFRASTRUCTURE TO DRIVE MARKET
 
 
 
 
 
16.4.5
AUSTRALIA
 
 
 
 
 
 
 
16.4.5.1
INCREASING INVESTMENT IN AI-ENABLED MEDICAL IMAGING AND DIAGNOSTIC INFRASTRUCTURE
 
 
 
 
 
16.4.6
SOUTH KOREA
 
 
 
 
 
 
 
 
STRONG GOVERNMENT AND INDUSTRY INVESTMENT IN AI-ENABLED
 
 
 
 
 
16.4.7
REST OF ASIA PACIFIC
 
 
 
 
 
16.5
LATIN AMERICA
 
 
 
 
 
 
 
16.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
 
 
16.5.2
BRAZIL
 
 
 
 
 
 
 
16.5.2.1
INCREASING INVESTMENT IN AI INFRASTRUCTURE AND MEDICAL IMAGING TO DRIVE MARKET
 
 
 
 
 
16.5.3
MEXICO
 
 
 
 
 
 
 
16.5.3.1
INCREASING DEPLOYMENT OF AI-ENABLED MEDICAL IMAGING INFRASTRUCTURE
 
 
 
 
 
16.5.4
REST OF LATIN AMERICA
 
 
 
 
 
 
 
16.5.4.1
GROWING ADOPTION OF AI IN MEDICAL IMAGING TO BOOST MARKET
 
 
 
 
16.6
MIDDLE EAST & AFRICA
 
 
 
 
 
 
 
16.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
 
 
 
 
 
 
16.6.2
GCC
 
 
 
 
 
 
 
16.6.2.1
EXPANDING HEALTHCARE DIGITALIZATION AND AI ADOPTION TO DRIVE MARKET
 
 
 
 
 
 
16.6.2.2
SAUDI ARABIA
 
 
 
 
 
 
 
 
16.6.2.2.1
ACCELERATING ADOPTION OF AI IN MEDICAL IMAGING – KEY DRIVER
 
 
 
 
16.6.2.3
UAE
 
 
 
 
 
 
 
 
16.6.2.3.1
GOVERNMENT-LED AI INITIATIVES FOR SMART HEALTHCARE TO BOOST MARKET
 
 
 
 
16.6.2.4
REST OF GCC
 
 
 
 
 
 
 
 
16.6.2.4.1
INCREASING HEALTHCARE DIGITIZATION TO DRIVE MARKET
 
 
 
16.6.3
SOUTH AFRICA
 
 
 
 
 
 
 
16.6.3.1
GROWING ADOPTION AND READINESS FOR AI-ENABLED MEDICAL IMAGING TO BOOST MARKET
 
 
 
 
 
16.6.4
REST OF MIDDLE EAST & AFRICA
 
 
 
 
17
COMPETITIVE LANDSCAPE
Discover strategic market moves and revenue trajectories shaping medical image analysis software leaders.
 
 
 
 
 
363
 
17.1
INTRODUCTION
 
 
 
 
 
 
17.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
 
 
17.2.1
OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
 
 
 
 
 
17.3
REVENUE ANALYSIS, 2021–2025
 
 
 
 
 
 
 
17.4
MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
 
17.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
 
 
 
 
 
 
 
 
17.5.1
STARS
 
 
 
 
 
 
17.5.2
EMERGING LEADERS
 
 
 
 
 
 
17.5.3
PERVASIVE PLAYERS
 
 
 
 
 
 
17.5.4
PARTICIPANTS
 
 
 
 
 
 
17.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
17.5.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
17.5.5.2
REGION FOOTPRINT
 
 
 
 
 
 
17.5.5.3
TYPE FOOTPRINT
 
 
 
 
 
 
17.5.5.4
TECHNOLOGY FOOTPRINT
 
 
 
 
 
 
17.5.5.5
IMAGE TYPE FOOTPRINT
 
 
 
 
17.6
COMPANY EVALUATION MATRIX: STARTUPS /SMES, 2025
 
 
 
 
 
 
 
 
17.6.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
17.6.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
17.6.3
DYNAMIC COMPANIES
 
 
 
 
 
 
17.6.4
STARTING BLOCKS
 
 
 
 
 
 
17.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
17.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
17.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
17.7
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
 
 
17.8
BRAND/SOFTWARE COMPARISON
 
 
 
 
 
 
17.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
17.9.1
PRODUCT/SERVICE LAUNCHES & UPGRADES
 
 
 
 
 
 
17.9.2
DEALS
 
 
 
 
 
 
17.9.3
EXPANSIONS
 
 
 
 
18
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
385
 
18.1
KEY PLAYERS
 
 
 
 
 
 
 
18.1.1
SIEMENS HEALTHINEERS AG
 
 
 
 
 
 
 
18.1.1.1
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
18.1.1.2
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
18.1.1.2.1
PRODUCT LAUNCHES & UPGRADES
 
 
 
 
 
 
18.1.1.2.2
DEALS
 
 
 
 
 
 
18.1.1.2.3
EXPANSIONS
 
 
 
 
18.1.1.3
MNM VIEW
 
 
 
 
 
 
 
 
18.1.1.3.1
KEY STRENGTHS
 
 
 
 
 
 
18.1.1.3.2
STRATEGIC CHOICES
 
 
 
 
 
 
18.1.1.3.3
WEAKNESSES AND COMPETITIVE THREATS
 
 
 
18.1.2
GE HEALTHCARE
 
 
 
 
 
 
18.1.3
KONINKLIJKE PHILIPS N.V.
 
 
 
 
 
 
18.1.4
CANON MEDICAL SYSTEMS CORPORATION
 
 
 
 
 
 
18.1.5
FUJIFILM HOLDINGS CORPORATION
 
 
 
 
 
 
18.1.6
AGFA-GEVAERT N.V.
 
 
 
 
 
 
18.1.7
CARESTREAM HEALTH
 
 
 
 
 
 
18.1.8
HOLOGIC, INC.
 
 
 
 
 
 
18.1.9
MERATIVE
 
 
 
 
 
 
18.1.10
SECTRA AB
 
 
 
 
 
 
18.1.11
BRUKER CORPORATION
 
 
 
 
 
 
18.1.12
QUIBIM
 
 
 
 
 
 
18.1.13
MIRADA MEDICAL LTD.
 
 
 
 
 
 
18.1.14
MEDIAN TECHNOLOGIES
 
 
 
 
 
 
18.1.15
ELUCID
 
 
 
 
 
 
18.1.16
RAPIDAI, INC.
 
 
 
 
 
 
18.1.17
MICROSOFT CORPORATION
 
 
 
 
 
 
18.1.18
TEMPUS AI, INC.
 
 
 
 
 
 
18.1.19
NANO-X IMAGING LTD
 
 
 
 
 
 
18.1.20
CONTEXTVISION AB
 
 
 
 
 
18.2
OTHER PLAYERS
 
 
 
 
 
 
 
18.2.1
VIZ.AI, INC.
 
 
 
 
 
 
18.2.2
AIDOC MEDICAL LTD.
 
 
 
 
 
 
18.2.3
AVICENNA.AI
 
 
 
 
 
 
18.2.4
CLEERLY, INC.
 
 
 
 
 
 
18.2.5
OVERJET, INC.
 
 
 
 
19
RESEARCH METHODOLOGY
 
 
 
 
 
468
 
19.1
RESEARCH APPROACH
 
 
 
 
 
 
 
19.1.1
SECONDARY RESEARCH
 
 
 
 
 
 
 
19.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
19.1.2
PRIMARY RESEARCH
 
 
 
 
 
 
 
19.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
19.1.2.2
INSIGHTS FROM PRIMARY EXPERTS
 
 
 
 
19.2
RESEARCH METHODOLOGY DESIGN
 
 
 
 
 
 
19.3
MARKET SIZE ESTIMATION
 
 
 
 
 
 
19.4
MARKET BREAKDOWN DATA TRIANGULATION
 
 
 
 
 
 
19.5
MARKET SHARE ESTIMATION
 
 
 
 
 
 
19.6
STUDY ASSUMPTIONS
 
 
 
 
 
 
19.7
LIMITATIONS
 
 
 
 
 
 
 
19.7.1
SCOPE-RELATED LIMITATIONS
 
 
 
 
 
 
19.7.2
METHODOLOGY-RELATED LIMITATIONS
 
 
 
 
 
19.8
RISK ASSESSMENT
 
 
 
 
 
20
APPENDIX
 
 
 
 
 
482
 
20.1
DISCUSSION GUIDE
 
 
 
 
 
 
20.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
20.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
20.4
RELATED REPORTS
 
 
 
 
 
 
20.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
USD EXCHANGE RATES
 
 
 
 
 
 
TABLE 2
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: PORTER’S FIVE FORCES
 
 
 
 
 
 
TABLE 3
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: ROLE IN ECOSYSTEM
 
 
 
 
 
 
TABLE 4
INDICATIVE PRICE FOR IMAGE ANALYSIS SOFTWARE PLATFORMS, BY KEY PLAYERS, 2025
 
 
 
 
 
 
TABLE 5
INDICATIVE PRICE FOR MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY REGION (2025)
 
 
 
 
 
 
TABLE 6
CASE 1: MERCY'S DEPLOYMENT OF AIDOC AIOS TO ACCELERATE MEDICAL IMAGE ANALYSIS AND CLINICAL TRIAGE
 
 
 
 
 
 
TABLE 7
CASE 2: ADVOCATE HEALTH'S EXPANSION OF AIDOC AI FOR ENTERPRISE MEDICAL IMAGING
 
 
 
 
 
 
TABLE 8
CASE 3: LUNIT'S AI-ASSISTED MAMMOGRAPHY SCREENING DEPLOYMENT AND CLINICAL VALIDATION
 
 
 
 
 
 
TABLE 9
US ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 10
JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET (JANUARY 2015 TO AUGUST 2026)
 
 
 
 
 
 
TABLE 11
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: KEY PATENTS/PATENT APPLICATIONS
 
 
 
 
 
 
TABLE 12
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 13
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 14
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 15
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 16
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 17
REGULATORY SCENARIO IN NORTH AMERICA
 
 
 
 
 
 
TABLE 18
REGULATORY SCENARIO IN EUROPE
 
 
 
 
 
 
TABLE 19
REGULATORY SCENARIO IN ASIA PACIFIC
 
 
 
 
 
 
TABLE 20
REGULATORY SCENARIO IN LATIN AMERICA
 
 
 
 
 
 
TABLE 21
REGULATORY SCENARIO IN MIDDLE EAST & AFRICA
 
 
 
 
 
 
TABLE 22
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
 
 
 
 
 
 
TABLE 23
KEY BUYING CRITERIA FOR TOP THREE END USERS
 
 
 
 
 
 
TABLE 24
UNMET NEEDS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
 
 
 
 
 
 
TABLE 25
END USER EXPECTATIONS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
 
 
 
 
 
 
TABLE 26
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 27
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR HOSPITALS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 28
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 29
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 30
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 31
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 32
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR RECONSTRUCTION & VISUALIZATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 33
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DETECTION & LOCALIZATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 34
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR SEGMENTATION & ANALYSIS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 35
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR REGISTRATION & COMPARISON, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 36
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR REPORTING & COMMUNICATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 37
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR CLINICAL DECISION SUPPORT, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 38
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 39
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR 3D IMAGING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 40
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR 4D IMAGING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR 2D IMAGING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 42
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 43
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR RADIOGRAPHY (X-RAY), BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 44
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 46
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR HIGH-END SLICE CT, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MID-END SLICE CT, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 48
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR LOW-END SLICE CT, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 50
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 51
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR CLOSED MRI SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 52
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OPEN MRI SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 54
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 55
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR 2D ULTRASOUND SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 56
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR 3D & 4D ULTRASOUND SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DOPPLER IMAGING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 58
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 59
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 60
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR POSITRON EMISSION TOMOGRAPHY (PET), BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 61
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT), BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 62
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAMMOGRAPHY, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 63
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 64
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR PET/CT, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 66
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR SPECT/CT, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR PET/MR, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 68
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 69
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 70
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 72
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MACHINE LEARNING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DEEP LEARNING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 74
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTER VISION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NATURAL LANGUAGE PROCESSING (NLP), BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 76
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR CONVENTIONAL TECHNOLOGY, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 77
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 78
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR CARDIOLOGY, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ONCOLOGY, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 80
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NEUROLOGY, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 81
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ORTHOPEDICS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 82
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DENTAL, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OBSTETRICS & GYNECOLOGY, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 84
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAMMOGRAPHY/BREAST IMAGING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 85
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 86
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 87
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR INTEGRATED SOFTWARE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 88
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR STANDALONE SOFTWARE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 89
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 90
NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 92
NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 94
NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 96
NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 98
NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 100
NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 102
NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 103
NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 104
US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 105
US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 106
US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 107
US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 108
US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 110
US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 112
US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 114
US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 116
US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 118
CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 120
CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 121
CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 122
CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 124
CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 126
CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 128
CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 130
EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 132
EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 134
EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 136
EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 137
EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 138
EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 140
EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/ HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 142
EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 144
GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 146
GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 148
GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 150
GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 152
GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 154
GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 156
GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 157
FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 158
FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 160
FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 162
FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 164
FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 166
FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 167
FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 168
FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 170
UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 172
UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 174
UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 176
UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 178
UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 179
UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 180
UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 182
UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 184
ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 186
ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 187
ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 188
ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 189
ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 190
ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 191
ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 192
ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 193
ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 194
ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 195
ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 196
SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 197
SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 198
SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 199
SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 200
SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 201
SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 202
SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 203
SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 204
SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 205
SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 206
SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 207
SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 208
SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 209
REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 210
REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 211
REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 212
REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 213
REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 214
REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 215
REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 216
REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 217
REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 218
REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 219
REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 220
REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 221
REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 222
ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 223
ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 224
ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 225
ASIA PACIFIC: AI-ENABLED TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 226
ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 227
ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 228
ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 229
ASIA PACIFIC: COMPUTED TOMOGRAPHY (CT) MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 230
ASIA PACIFIC: MAGNETIC RESONANCE IMAGING (MRI) MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 231
ASIA PACIFIC: ULTRASOUND IMAGING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 232
ASIA PACIFIC: NUCLEAR IMAGING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 233
ASIA PACIFIC: COMBINED/HYBRID MODALITIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 234
ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 235
ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 236
CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 237
CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 238
CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 239
CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 240
CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 241
CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 242
CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 243
CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 244
CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 245
CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 246
CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 247
CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 248
CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 249
JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 250
JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 251
JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 252
JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 253
JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 254
JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 255
JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 256
JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 257
JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 258
JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 259
JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 260
JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 261
JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 262
INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 263
INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 264
INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 265
INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 266
INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 267
INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 268
INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE FOR COMPUTED TOMOGRAPHY (CT) MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 269
INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 270
INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 271
INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 272
INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE FOR COMBINED/HYBRID MODALITIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 273
INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 274
INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 275
AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 276
AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 277
AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 278
AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 279
AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 280
AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 281
AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 282
AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 283
AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 284
AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 285
AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 286
AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 287
AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 288
SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 289
SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 290
SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 291
SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 292
SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 293
SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 294
SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 295
SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 296
SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 297
SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 298
SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 299
SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 300
SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 301
REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 302
REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 303
REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 304
REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 305
REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 306
REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 307
REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 308
REST OF ASIA PACIFIC: MAGNETIC RESONANCE IMAGING (MRI) MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 309
REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 310
REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 311
REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 312
REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 313
REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 314
LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 315
LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 316
LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 317
LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 318
LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 319
LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 320
LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 321
LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 322
LATIN AMERICA: MAGNETIC RESONANCE IMAGING (MRI) MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 323
LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 324
LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 325
LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 326
LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 327
LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 328
BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 329
BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 330
BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 331
BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 332
BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 333
BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 334
BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 335
BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 336
BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 337
BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 338
BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 339
BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 340
BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 341
MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 342
MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 343
MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 344
MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 345
MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 346
MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 347
MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT) MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 348
MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 349
MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 350
MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 351
MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 352
MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 353
MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 354
REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 355
REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 356
REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 357
REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 358
REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 359
REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 360
REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 361
REST OF LATIN AMERICA: MAGNETIC RESONANCE IMAGING (MRI) MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 362
REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 363
REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 364
REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 365
REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 366
REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 367
MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 368
MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 369
MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 370
MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 371
MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 372
MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 373
MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 374
MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 375
MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 376
MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 377
MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 378
MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 379
MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 380
MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 381
GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 382
GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 383
GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 384
GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 385
GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 386
GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 387
GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 388
GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 389
GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 390
GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 391
GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 392
GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/ HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 393
GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 394
GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 395
SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 396
SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 397
SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 398
SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 399
SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 400
SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 401
SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 402
SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 403
SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 404
SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 405
SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 406
SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 407
SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 408
UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 409
UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 410
UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 411
UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 412
UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 413
UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 414
UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 415
UAE: MEDICAL IMAGING ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 416
UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 417
UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 418
UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 419
UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 420
UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 421
REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 422
REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 423
REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 424
REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 425
REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 426
REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 427
REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 428
REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 429
REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 430
REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 431
REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 432
REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 433
REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 434
SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 435
SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 436
SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 437
SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 438
SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 439
SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 440
SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 441
SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 442
SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 443
SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 444
SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 445
SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 446
SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 447
REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 448
REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 449
REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 450
REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 451
REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 452
REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 453
REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 454
REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 455
REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 456
REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 457
REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 458
REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 459
REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 460
OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES
 
 
 
 
 
 
TABLE 461
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: DEGREE OF COMPETITION, 2025
 
 
 
 
 
 
TABLE 462
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 463
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: TYPE FOOTPRINT
 
 
 
 
 
 
TABLE 464
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: TECHNOLOGY FOOTPRINT
 
 
 
 
 
 
TABLE 465
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: IMAGE TYPE FOOTPRINT
 
 
 
 
 
 
TABLE 466
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 467
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 468
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: PRODUCT/SERVICE LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 469
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 470
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: EXPANSIONS, JANUARY 2023– AUGUST 2026
 
 
 
 
 
 
TABLE 471
SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 472
SIEMENS HEALTHINEERS AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 473
SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 474
SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 475
SIEMENS HEALTHINEERS: EXPANSIONS, JANUARY 2023–JULY 2026
 
 
 
 
 
 
TABLE 476
GE HEALTHCARE: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 477
GE HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 478
GE HEALTHCARE: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023– AUGUST 2026
 
 
 
 
 
 
TABLE 479
GE HEALTHCARE: DEALS, JANUARY 2023– AUGUST 2026
 
 
 
 
 
 
TABLE 480
KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 481
KONINKLIJKE PHILIPS N.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 482
KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023– AUGUST 2026
 
 
 
 
 
 
TABLE 483
KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 484
KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 485
CANON MEDICAL SYSTEMS CORPORATION: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 486
CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS/SOLUTIONS/ SERVICES OFFERED
 
 
 
 
 
 
TABLE 487
CANON MEDICAL SYSTEMS CORPORATION: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023– AUGUST 2026
 
 
 
 
 
 
TABLE 488
CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 489
FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 490
FUJIFILM HOLDINGS CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 491
FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 492
FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 493
AGFA-GEVAERT N.V.: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 494
AGFA-GEVAERT N.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 495
AGFA-GEVAERT N.V.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023– AUGUST 2026
 
 
 
 
 
 
TABLE 496
AGFA-GEVAERT N.V.: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 497
CARESTREAM HEALTH: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 498
CARESTREAM HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 499
CARESTREAM HEALTH: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023– AUGUST 2026
 
 
 
 
 
 
TABLE 500
CARESTREAM HEALTH: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 501
HOLOGIC, INC.: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 502
HOLOGIC, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 503
HOLOGIC, INC.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 504
HOLOGIC, INC.: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 505
MERATIVE: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 506
MERATIVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 507
MERATIVE: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 508
MERATIVE: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 509
MERATIVE: EXPANSIONS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 510
SECTRA AB: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 511
SECTRA AB: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 512
SECTRA AB: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023– AUGUST 2026
 
 
 
 
 
 
TABLE 513
SECTRA AB: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 514
BRUKER CORPORATION: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 515
BRUKER CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 516
QUIBIM: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 517
QUIBIM: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 518
QUIBIM: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 519
MIRADA MEDICAL LTD.: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 520
MIRADA MEDICAL LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 521
MIRADA MEDICAL LTD.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 522
MIRADA MEDICAL LTD.: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 523
MIRADA MEDICAL LTD.: OTHER DEVELOPMENTS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 524
MEDIAN TECHNOLOGIES: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 525
MEDIAN TECHNOLOGIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 526
MEDIAN TECHNOLOGIES: PRODUCTS LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 527
MEDIAN TECHNOLOGIES: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 528
ELUCID: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 529
ELUCID: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 530
ELUCID: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 531
ELUCID: OTHER DEVELOPMENTS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 532
RAPIDAI INC.: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 533
RAPIDAI INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 534
RAPIDAI INC.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 535
RAPIDAI INC.: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 536
MICROSOFT CORPORATION: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 537
MICROSOFT CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 538
MICROSOFT CORPORATION: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 539
MICROSOFT CORPORATION: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 540
TEMPUS AI, INC.: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 541
TEMPUS AI, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 542
TEMPUS AI, INC.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 543
TEMPUS AI, INC.: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 544
NANO-X IMAGING LTD: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 545
NANO-X IMAGING LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 546
NANO-X IMAGING LTD: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 547
NANO-X IMAGING LTD: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 548
CONTEXTVISION AB: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 549
CONTEXTVISION AB: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 550
CONTEXTVISION AB: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 551
CONTEXTVISION AB: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 552
RISK ASSESSMENT: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
MARKET SCENARIO
 
 
 
 
 
 
FIGURE 2
GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2024–2031
 
 
 
 
 
 
FIGURE 3
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2023–2026
 
 
 
 
 
 
FIGURE 4
DISRUPTIONS INFLUENCING GROWTH OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
 
 
 
 
 
 
FIGURE 5
HIGH-GROWTH SEGMENTS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2026–2031
 
 
 
 
 
 
FIGURE 6
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 7
RISING DEMAND FOR MEDICAL IMAGE ANALYSIS SOFTWARE AND INCREASED ADOPTION TO REDUCE DIAGNOSIS TIMELINES & COSTS TO DRIVE GROWTH
 
 
 
 
 
 
FIGURE 8
INTEGRATED SOFTWARE ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2025
 
 
 
 
 
 
FIGURE 9
INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 10
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 11
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 12
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 13
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
FIGURE 14
RECENT FUNDING OF PLAYERS IN THE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
 
 
 
 
 
 
FIGURE 15
PATENT PUBLICATION TRENDS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2015–2026
 
 
 
 
 
 
FIGURE 16
JURISDICTION AND TOP APPLICANT ANALYSIS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET (JANUARY 2015 TO AUGUST 2026)
 
 
 
 
 
 
FIGURE 17
TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET (JANUARY 2015 TO AUGUST 2026)
 
 
 
 
 
 
FIGURE 18
MARKET POTENTIAL OF AI/GEN AI ON MEDICAL IMAGE ANALYSIS SOFTWARE ACROSS END USERS
 
 
 
 
 
 
FIGURE 19
IMPACT OF AI/GEN AI ON INTERCONNECTED & ADJACENT ECOSYSTEMS
 
 
 
 
 
 
FIGURE 20
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
 
 
 
 
 
 
FIGURE 21
KEY BUYING CRITERIA FOR TOP THREE END USERS
 
 
 
 
 
 
FIGURE 22
NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 23
ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 24
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: REVENUE ANALYSIS OF TOP FIVE PLAYERS, 2021–2025
 
 
 
 
 
 
FIGURE 25
MARKET SHARE ANALYSIS OF COMPANIES OFFERING MEDICAL IMAGE ANALYSIS SOFTWARE SERVICES/SOLUTIONS, 2025
 
 
 
 
 
 
FIGURE 26
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
 
 
 
 
 
 
FIGURE 27
FOOTPRINT OF COMPANIES IN THE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
 
 
 
 
 
 
FIGURE 28
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 29
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF MEDICAL IMAGE ANALYSIS SOFTWARE VENDORS
 
 
 
 
 
 
FIGURE 30
FINANCIAL METRICS (EV/EBITDA)
 
 
 
 
 
 
FIGURE 31
BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
 
 
FIGURE 32
SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 33
GE HEALTHCARE: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 34
KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 35
CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 36
FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 37
AGFA-GEVAERT N.V.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 38
SECTRA AB: COMPANY SNAPSHOT (2026)
 
 
 
 
 
 
FIGURE 39
BRUKER CORPORATION: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 40
MEDIAN TECHNOLOGIES: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 41
MICROSOFT CORPORATION: COMPANY SNAPSHOT (2026)
 
 
 
 
 
 
FIGURE 42
TEMPUS AI, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 43
NANO-X IMAGING LTD: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 44
CONTEXTVISION AB: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 45
RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 46
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
 
 
FIGURE 47
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
 
 
 
 
 
 
FIGURE 48
BOTTOM-UP APPROACH
 
 
 
 
 
 
FIGURE 49
TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 50
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 51
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: CAGR PROJECTION ANALYSIS
 
 
 
 
 
 
FIGURE 52
DATA TRIANGULATION METHODOLOGY
 
 
 
 
 
 

Methodology

The study involved five major activities to estimate the current size of the medical image analysis software market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for the study of the medical image analysis software market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global medical image analysis software market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (hospital directors, hospital vice presidents, department heads, and critical care specialists) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

Breakdown of Primary Interviews

Medical Image Analysis Software Market 
 Size, and Share

Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Tiers of companies are defined on the basis of their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the medical image analysis software market. These methods were also used extensively to estimate the size of various subsegments in the market.

Top-Down and Bottom-Up Approach

Medical Image Analysis Software Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the medical image analysis software market.

Market Definition

Medical image analysis software refers to computer-based tools that help clinicians detect, measure, and interpret findings from medical images such as CT, MRI, ultrasound, and X-ray scans. This software aims to reduce radiologists' manual workload while improving diagnostic accuracy and speed. By automating tasks such as abnormality detection and image reporting, hospitals and diagnostic centers can help radiologists focus on complex clinical decisions rather than routine image review.

Key Stakeholders

  • Medical imaging equipment manufacturers
  • AI software vendors/developers
  • Hospitals and diagnostic imaging centers
  • Radiologists and healthcare providers
  • Academic and research institutions
  • Regulatory bodies (e.g., FDA, EMA)
  • Healthcare IT/PACS-RIS integration partners
  • Cloud service providers
  • Venture capitalists and private equity investors
  • Business research and consulting service providers

Report Objectives

  • To define, describe, and forecast the global medical image analysis software market based on type, technology, function, image type, modality, therapeutic area, end user, and region
  • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing market growth
  • To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall medical image analysis software market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To strategically analyze the market structure profile of the key players of the medical image analysis software market and comprehensively analyze their core competencies
  • To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To track and analyze competitive developments such as product launches, investments, partnerships, collaborations, acquisitions, expansions, product approvals, and alliances in the medical image analysis software market during the forecast period

Available customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs.

The following customization options are available for the report:

  • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
  • Geographic Analysis: Further breakdown of Latin America, Europe, and the Middle East & Africa medical image analysis software into specific countries.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Medical Image Analysis Software Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Medical Image Analysis Software Market

DMCA.com Protection Status
popup img